Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Seksuel dysfunktion hos kvinder som laegemiddelbivirkning

Research output: Contribution to journalReviewResearchpeer-review

Harvard

APA

CBE

MLA

Vancouver

Author

Bibtex

@article{d34901267a68455da7d41b021a98f803,
title = "Seksuel dysfunktion hos kvinder som laegemiddelbivirkning",
abstract = "This review describes female sexual dysfunction (FSD) as an adverse effect to pharmacological treatment. FSD covers libido, arousal, orgasm, and pain problems. The existing knowledge of the influence of medication upon female sexual function is very sparse. Treatment with SSRIs and other antidepressants may cause decreased libido and organism problems. Antipsychotic treatment often causes libido, lubrication, and orgasm problems. Spironolactone may cause decreased libido and impaired lubrication. Whether antihypertensives, H2-receptor antagonists and sex hormones have sexual adverse effects has not been clarified properly. Some drugs, such as bupropion and sildenafil, may enhance the sexual function, but further studies have to be carried out. The need for further research on the topic is stressed.",
keywords = "Antidepressive Agents/adverse effects, Antihypertensive Agents/adverse effects, Contraceptives, Oral/adverse effects, Drug-Related Side Effects and Adverse Reactions, Estrogen Replacement Therapy/adverse effects, Female, Humans, Libido/drug effects, Orgasm/drug effects, Sexual Behavior/drug effects, Sexual Dysfunction, Physiological/chemically induced, Sexual Dysfunctions, Psychological/chemically induced",
author = "Giraldi, {Annamaria G Elena} and Jette Victor",
year = "2002",
month = oct,
day = "7",
language = "Dansk",
volume = "164",
pages = "4757--60",
journal = "Ugeskrift for Laeger",
issn = "0041-5782",
publisher = "Almindelige Danske Laegeforening",
number = "41",

}

RIS

TY - JOUR

T1 - Seksuel dysfunktion hos kvinder som laegemiddelbivirkning

AU - Giraldi, Annamaria G Elena

AU - Victor, Jette

PY - 2002/10/7

Y1 - 2002/10/7

N2 - This review describes female sexual dysfunction (FSD) as an adverse effect to pharmacological treatment. FSD covers libido, arousal, orgasm, and pain problems. The existing knowledge of the influence of medication upon female sexual function is very sparse. Treatment with SSRIs and other antidepressants may cause decreased libido and organism problems. Antipsychotic treatment often causes libido, lubrication, and orgasm problems. Spironolactone may cause decreased libido and impaired lubrication. Whether antihypertensives, H2-receptor antagonists and sex hormones have sexual adverse effects has not been clarified properly. Some drugs, such as bupropion and sildenafil, may enhance the sexual function, but further studies have to be carried out. The need for further research on the topic is stressed.

AB - This review describes female sexual dysfunction (FSD) as an adverse effect to pharmacological treatment. FSD covers libido, arousal, orgasm, and pain problems. The existing knowledge of the influence of medication upon female sexual function is very sparse. Treatment with SSRIs and other antidepressants may cause decreased libido and organism problems. Antipsychotic treatment often causes libido, lubrication, and orgasm problems. Spironolactone may cause decreased libido and impaired lubrication. Whether antihypertensives, H2-receptor antagonists and sex hormones have sexual adverse effects has not been clarified properly. Some drugs, such as bupropion and sildenafil, may enhance the sexual function, but further studies have to be carried out. The need for further research on the topic is stressed.

KW - Antidepressive Agents/adverse effects

KW - Antihypertensive Agents/adverse effects

KW - Contraceptives, Oral/adverse effects

KW - Drug-Related Side Effects and Adverse Reactions

KW - Estrogen Replacement Therapy/adverse effects

KW - Female

KW - Humans

KW - Libido/drug effects

KW - Orgasm/drug effects

KW - Sexual Behavior/drug effects

KW - Sexual Dysfunction, Physiological/chemically induced

KW - Sexual Dysfunctions, Psychological/chemically induced

M3 - Review

C2 - 12407875

VL - 164

SP - 4757

EP - 4760

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

SN - 0041-5782

IS - 41

ER -

ID: 55814725